2026 NPPES data Dermatopathology Physician NPI 1821030271 M.D.
Verify on CMS →

AMARA LIEBERMAN, M.D.

Dermatopathology Physician in BALA CYNWYD, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
495
Medicare Part D claims · 239 beneficiaries · Dermatopathology Physician avg: 650
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

AMARA LIEBERMAN, M.D. filed 495 Medicare Part D claims in 2023 as a Dermatopathology Physician in BALA CYNWYD, Pennsylvania, prescribing 90% generic.

495
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMARA LIEBERMAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

495 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

AMARA LIEBERMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AMARA LIEBERMAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/11/2006

NPI 1821030271

Primary specialty

Dermatopathology Physician

Niche

570 US NPIs in this specialty

Medicare Part D claims

495 24% vs specialty avg

2023 prescription claims

Specialty avg: 650

Specialty distribution in Pennsylvania

How Dermatopathology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Dermatopathology Physician share within Pennsylvania

1. Dermatopathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatopathology Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Dermatopathology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatopathology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatopathology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatopathology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMARA LIEBERMAN, M.D. appears in the CMS NPPES registry as a Dermatopathology Physician provider holding M.D. credentials at 1 BALA PLZ, BALA CYNWYD, PA, 19004, with a listed phone of (610) 664-3300. NPI 1821030271 was issued on 06/11/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIEBERMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 495 prescription claims written by this provider, covering 239 Medicare beneficiaries and totaling roughly $107K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatopathology Physician is a narrow specialty nationwide, with 570 enrolled providers across 48 states and an average of 650 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1 BALA PLZ
BALA CYNWYD, PA 19004

Provider Details

NPI 1821030271
Specialty Dermatopathology Physician
Credentials M.D.
Gender Female
NPI Issued 06/11/2006

Hospital and facility affiliations

Facilities where AMARA LIEBERMAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PERMANENTE MEDICAL GROUP INC
STOCKTON, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to AMARA LIEBERMAN, M.D.. To verify AMARA LIEBERMAN, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

AMARA LIEBERMAN, M.D. — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 495 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

495
Total Claims
$107K
Total Drug Cost
239
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
554
Total Day Supply
14,833
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$92K
Generic Drug Cost
$14K
Antibiotic Claims
31

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
0.91
Gender Split
56% female / 44% male
Age Distribution
<65: 13, 65-74: 150, 75-84: 65, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AMARA LIEBERMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
70
Fluorouracil
68
Fluocinonide
37
Metronidazole
31
Clobetasol Propionate
24
Doxycycline Monohydrate
24
Ketoconazole
24
Mupirocin
20
Triamcinolone Acetonide
20
Clindamycin Phosphate
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatopathology Physician Overview

How AMARA LIEBERMAN, M.D. fits within the Dermatopathology Physician landscape nationally.

570
Dermatopathology Physician Providers in US
48
States with Dermatopathology Physician
650
Avg Claims per Provider

AMARA LIEBERMAN, M.D.'s 495 claims are below the specialty average of 650.

Nearby Dermatopathology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as LIEBERMAN.

Compare Dermatopathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMARA LIEBERMAN, M.D.'s specialty?
AMARA LIEBERMAN, M.D. specializes in Dermatopathology Physician and practices in BALA CYNWYD, Pennsylvania. Credentials: M.D..
How much does AMARA LIEBERMAN, M.D. prescribe under Medicare Part D?
In 2023, AMARA LIEBERMAN, M.D. wrote 495 Medicare Part D claims totaling $107K in drug costs for 239 beneficiaries.
Where is AMARA LIEBERMAN, M.D. located?
AMARA LIEBERMAN, M.D. is located at 1 BALA PLZ, BALA CYNWYD, PA, 19004. Phone: (610) 664-3300.
What is AMARA LIEBERMAN, M.D.'s NPI number?
AMARA LIEBERMAN, M.D.'s National Provider Identifier (NPI) is 1821030271, issued on 06/11/2006.
Does AMARA LIEBERMAN, M.D. prescribe more brand-name or generic drugs?
AMARA LIEBERMAN, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $92K in brand drug costs.
How many Dermatopathology Physician providers are there in the US?
There are 570 Dermatopathology Physician providers across 48 states in the US. The average Dermatopathology Physician provider writes 650 Medicare Part D claims per year.
What drugs does AMARA LIEBERMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, AMARA LIEBERMAN, M.D.'s most frequently prescribed drugs include Betamethasone Diprop Augmented, Fluorouracil, Fluocinonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMARA LIEBERMAN, M.D. accept Medicare?
AMARA LIEBERMAN, M.D. appears in CMS Medicare data with 495 Part D claims and 239 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMARA LIEBERMAN, M.D.'s credentials?
AMARA LIEBERMAN, M.D.'s NPI is 1821030271 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology